ILUMYA
tildrakizumab-asmn
Listed by Sun Pharmaceutical Industries, Inc.
- Strength
- 100 mg/mL
- Form
- Injection, Solution
- Route
- Subcutaneous
- Class
- Interleukin-23 Antagonist
What it contains
- Tildrakizumab 100 mg/mL
FDA record
| Dosage form | Injection, Solution |
|---|---|
| Route | Subcutaneous |
| Drug class | Interleukin-23 Antagonist |
| Approval route | BLA — biologic licence |
| NDC code | 47335-177 |
| FDA application | BLA761067 |
| RxNorm concept | 2053453 |
| Package sizes listed | 4 |
| Marketed since | August 2018 |
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.